ClinicalTrials.gg
RecruitingNCT06712628UP-RISINGUpdated Nov 19, 2026

A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

An observational study in Moderate to Severe Rheumatoid Arthritis, sponsored by AbbVie. Recruiting at 76 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by AbbVie · Observational

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Updated Nov 19, 20267 sites added3 sites removedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
678
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 80 studies in Arthritis, Rheumatoid by AbbVie — 5 open to participants now, 6 under way, 1 of them phase 3. Arthritis, Rheumatoid · AbbVie.

Planned enrollment
13th of 41
678 · median 401
Started
2024
the only one that year
Observational
41 of 80
1 open now
Registered
76th of 80
by date

Among the 80 studies in Arthritis, Rheumatoid by AbbVie, this one is the 13th largest by planned enrollment of the 41 observational ones that give a count, is the only one that started in 2024, is one of 41 observational ones, and was the 76th registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

5 of the 80 studies in Arthritis, Rheumatoid by AbbVie are open now, in 12 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 80 studies in Arthritis, Rheumatoid by AbbVie, or all of them as a file.
02

Study summary

This study will compare the retention rates for UPA vs. TNFi treatment in adult participants with moderate to severe active RA per local label and according to local standard of care

This is a mono-country, prospective, multi-center observational study in patients with moderate to severe active RA receiving UPA or TNFi therapy. Around 678 participants will be enrolled in approximately 80 sites in Germany.

Study recruitment will last approximately 24 months, and the study participation time will be up to 24 months, for a total study duration of approximately 48 months.

03

Conditions studied

  • Moderate to Severe Rheumatoid Arthritis

Keywords

  • Moderate to Severe Rheumatoid Arthritis
  • Rheumatoid Arthritis
  • Upadacitinib
  • Tumor Necrosis Factor Inhibitor Treatment
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants with moderate to severe active Rheumatoid Arthritis receiving Upadcitinib or a Tumor necrosis factor inhibitor treatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current or Past participants with a confirmed diagnosis of moderate to severe active RA upon judgement of the treating physician.
  • Physician decision on participant treatment with Upadacitinib (UPA) or tumor necrosis factor inhibitor (TNFi) must have been reached prior to and independently of recruitment in the study
  • UPA or TNFi prescribed in accordance with the applicable approved label and local regulatory and reimbursement policies

Exclusion criteria

Exclusion Criteria:

  • Participation in a clinical trial with an drug (within a minimum of 30 days or 5 half-lives of the investigational drug [whichever is longer] prior to baseline)
  • Prior treatment with Upadacitinib
  • Prior treatment with the same tumor necrosis factor inhibitor as the one prescribed for this study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
678 participants (estimated)

Groups and cohorts

  • Upadacitinib

    Participants will receive upadacitinib as prescribed by their physician according to local label.

  • Tumor Necrosis Factor Inhibitor-Treatment

    Participants will receive a tumor necrosis factor inhibitor treatment as prescribed by their physician according to local label.

06

What researchers measure

Primary outcomes

  1. Retention Rate of UPA vs TNFi

    Time to the discontinuation of Upadacitinib. Time to the discontinuation of Tumor Necrosis Factor Inhibitor treatment

    Time frame: Up to approximately 24 months

07

Study locations

75 of 76 sites recruiting
  • Gemeinschaftspraxis Innere Medizin/Rheumatologie /ID# 278584
    Freiburg im Breisgau, Baden-Wurttemberg 79098, Germany
    Recruiting
  • Rheumapraxis Heidelberg /ID# 276475
    Heidelberg, Baden-Wurttemberg 69120, Germany
    Recruiting
  • Rheumapraxis Haas Tubingen /ID# 275536
    Tübingen, Baden-Wurttemberg 72072, Germany
    Recruiting
  • Rheumapraxis Ulm Dr. med. Nadia Rinaldi /ID# 276293
    Ulm, Baden-Wurttemberg 89073, Germany
    Recruiting
  • Dr. Med. Thomas Marycz /ID# 274646
    Amberg, Bavaria 92224, Germany
    Recruiting
  • Rheumapraxis Am Webereck /ID# 274412
    Augsburg, Bavaria 86157, Germany
    Recruiting
  • Private Practice - Dr. Karin Manger /ID# 287347
    Bamberg, Bavaria 96047, Germany
    Recruiting
  • Praxisgemeinschaft Rheumatologie Nephrologie Erlangen /ID# 286648
    Erlangen, Bavaria 91056, Germany
    Recruiting
  • Dr. Harmuth /ID# 273401
    Marktredwitz, Bavaria 95615, Germany
    Recruiting
  • Praxiszentrum Dr. Med. Klaus Kruger Dres. Günther Kellerer Und Paul Kellerer /ID# 276138
    Munich, Bavaria 81541, Germany
    Recruiting
  • Klinische Forschung Im Medizinischen Versorgungalltag Gbr /ID# 274587
    Planegg, Bavaria 82152, Germany
    Recruiting
  • Medikomp Mvz /ID# 285898
    Elsterwerda, Brandenburg 04910, Germany
    Recruiting
  • Private Practice - Dr. Dirk Wernicke /ID# 276820
    Hohen Neuendorf, Brandenburg 16540, Germany
    Recruiting
  • Praxis K. Pagel /ID# 279121
    Hoppegarten, Brandenburg 15366, Germany
    Recruiting
  • Rheumahaus Studien GbR /ID# 275917
    Potsdam, Brandenburg 14467, Germany
    Recruiting
  • Rheumatologisch Immunologisch /ID# 275830
    Templin, Brandenburg 17268, Germany
    Recruiting
  • Rheumatism Center Mittelhessen /ID# 274641
    Bad Endenbach, Hesse 35080, Germany
    Recruiting
  • Deutsches Endokrinologisches Versorgungszentrum DEVZ - MVZ GdR /ID# 274291
    Frankfurt am Main, Hesse 60329, Germany
    Recruiting
  • Mvz Dr. Med. Mahdy and Kollegen - Braunschweig /ID# 284988
    Braunschweig, Lower Saxony 38106, Germany
    Recruiting
  • Stadtisches Klinikum Braunschweig /ID# 282626
    Braunschweig, Lower Saxony 38126, Germany
    Recruiting
  • Private Practice - Dr. Jorg Sensse /ID# 281907
    Gifhorn, Lower Saxony 38518, Germany
    Recruiting
  • Rheumatologische Facharztpraxis /ID# 286591
    Hanover, Lower Saxony 30159, Germany
    Recruiting
  • Rheumapraxis Hannover-List /ID# 273735
    Hanover, Lower Saxony 30161, Germany
    Recruiting
  • Praxis. F. Bigdeli-Wilshusen /ID# 273455
    Hanover, Lower Saxony 30173, Germany
    Recruiting
  • Rheumatologie Kassel /ID# 275916
    Kassel, Lower Saxony 34125, Germany
    Recruiting
  • Rheumapraxis An Der Hase /ID# 276949
    Osnabrück, Lower Saxony 49074, Germany
    Recruiting
  • Fachpraxis fur Rheumatologie und Osteologie /ID# 275359
    Weyhe, Lower Saxony 28844, Germany
    Recruiting
  • Dr. Ann-Dorthe Holst /ID# 285741
    Ludwigslust, Mecklenburg-Vorpommern 19288, Germany
    Recruiting
  • Private Practice - Dr. Thilo Klopsch - Stargarder Strasse /ID# 276367
    Neubrandenburg, Mecklenburg-Vorpommern 17033, Germany
    Recruiting
  • Rheumatologische Facharztpraxis - Schwerin /ID# 284785
    Schwerin, Mecklenburg-Vorpommern 19053, Germany
    Recruiting
  • Klinikum Bielefeld Rosenhohe /ID# 283715
    Bielefeld, North Rhine-Westphalia 33647, Germany
    Recruiting
  • Rheumatology Euskirchen /ID# 285419
    Euskirchen, North Rhine-Westphalia 53879, Germany
    Recruiting
  • Rheumazentrum Ruhrgebiet /ID# 275518
    Herne, North Rhine-Westphalia 44649, Germany
    Recruiting
  • St.Elisabeth Hospital Meerbusch /ID# 275030
    Meerbusch, North Rhine-Westphalia 40668, Germany
    Recruiting
  • Gesundheitscampus Monheim /ID# 283726
    Monheim am Rhein, North Rhine-Westphalia 40789, Germany
    Recruiting
  • Rheumazentrum Ratingen /ID# 275707
    Ratingen, North Rhine-Westphalia 40882, Germany
    Recruiting
  • Praxis Dr. med. Florian Beyer /ID# 274293
    Kaiserslautern, Rhineland-Palatinate 67657, Germany
    Recruiting
  • Private Practice - Dr. Alexander Lautwein /ID# 282328
    Wittlich, Rhineland-Palatinate 54516, Germany
    Recruiting
  • Rheumapraxis Zweibruecken - Matar /ID# 282656
    Zweibrücken, Rhineland-Palatinate 66482, Germany
    Recruiting
  • Rheumapraxis am Schlossberg /ID# 272728
    Homburg, Saarland 66424, Germany
    Recruiting
  • Dr. Murawski /ID# 272724
    Neunkirchen, Saarland 66538, Germany
    Recruiting
  • Knappschaftsklinikum Saar /ID# 279852
    Püttlingen, Saarland 66346, Germany
    Recruiting
  • Rheumapraxis Dr. Prothmann /ID# 279851
    Püttlingen, Saarland 66346, Germany
    Recruiting
  • Medizinischen Versorgungszentrums Agilomed /ID# 274887
    Chemnitz, Saxony 09130, Germany
    Recruiting
  • Schwerpunktpraxis Rheumatologie und Klinische Immunologie /ID# 282628
    Dresden, Saxony 01097, Germany
    Recruiting
  • Dr. Mueller /ID# 273081
    Freiberg, Saxony 09599, Germany
    Recruiting
  • Private Practice - Dr. Frank Hamann, Dr. Andreas Teich & Dr. Konrad Boche /ID# 275358
    Leipzig, Saxony 04109, Germany
    Recruiting
  • Private Practice - Dr. Ilka Schwarze /ID# 276981
    Leipzig, Saxony 04129, Germany
    Recruiting
  • Private Practice - Dr. Christine Baumann /ID# 275095
    Plauen, Saxony 08523, Germany
    Recruiting
  • Praxis H. Fricke-Wagner /ID# 274467
    Zwickau, Saxony 08056, Germany
    Recruiting
  • Rheumapraxis Dr. Liebhaber /ID# 274888
    Halle, Saxony-Anhalt 06128, Germany
    Recruiting
  • Rheumatologische Facharztpraxis - Magdeburg /ID# 272866
    Magdeburg, Saxony-Anhalt 39104, Germany
    Recruiting
  • Private Practice- Dr. Joerdis Gerigk /ID# 283747
    Magdeburg, Saxony-Anhalt 39106, Germany
    Recruiting
  • Rheumatologische Facharztpraxis - Naumburg (Saale) /ID# 272743
    Naumburg, Saxony-Anhalt 06618, Germany
    Recruiting
  • Rheumatologische Schwerpunktpraxis Rendsburg /ID# 280069
    Rendsburg, Schleswig-Holstein 24768, Germany
    Recruiting
  • Private Practice - Dr. Thomas Kupka /ID# 273631
    Altenburg, Thuringia 04600, Germany
    Recruiting
  • Rheumapraxis Weimar /ID# 272740
    Weimar, Thuringia 99427, Germany
    Recruiting
  • MVZ Weserbergland /ID# 276009
    Bad Pyrmont, 31812, Germany
    Completed

    Not enrolling at this site — choose another above.

  • Rheumatologische Schwerpunktpraxis /ID# 280323
    Berlin, 10777, Germany
    Recruiting
  • Rheumatologisches Versorgungszentrum Steglitz /ID# 289145
    Berlin, 12163, Germany
    Recruiting
  • Private Practice - Dr. Silke Zinke /ID# 276366
    Berlin, 13055, Germany
    Recruiting
  • Rheumapraxis am Schlachtensee /ID# 287793
    Berlin, 14129, Germany
    Recruiting
  • MVZ Herzogin Elisabeth Hospital /ID# 272725
    Braunschweig, 38114, Germany
    Recruiting
  • Private Practice - Dr. Sebastian Schuh /ID# 272731
    Coburg, 96450, Germany
    Recruiting
  • MVZ-Medizinisches Versorgungszentrum Daun GmbH /ID# 285725
    Daun, 54550, Germany
    Recruiting
  • Rheumapraxis Düren /ID# 272726
    Düren, 52355, Germany
    Recruiting
  • Praxis Dilltal /ID# 272727
    Ehringshausen, 35630, Germany
    Recruiting
  • Private Practice - Dr. Daniel Bestler /ID# 272741
    Erfurt, 99096, Germany
    Recruiting
  • Praxis Fiene /ID# 279410
    Greifswald, 17493, Germany
    Recruiting
  • Private Practice - Dr Hauke E Heintz /ID# 278081
    Hamburg, 22391, Germany
    Recruiting
  • Rheumapraxis Kaufering /ID# 283852
    Kaufering, 86916, Germany
    Recruiting
  • Prof-med-stud.de /ID# 285869
    Munich, 80935, Germany
    Recruiting
  • Die Fachaerzte im Rottal - Nephrologie, Rheumatologie /ID# 284221
    Pfarrkirchen, 84347, Germany
    Recruiting
  • Praxis F. Schattenberg /ID# 280322
    Waren, 17192, Germany
    Recruiting
  • Cellitinnen-Krankenhaus St. Josef /ID# 275926
    Wuppertal, 42105, Germany
    Recruiting
  • Praxis Barmen /ID# 277514
    Wuppertal, 42285, Germany
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2028, 49 months after the start.

Of 155 industry-sponsored observational studies under Arthritis, Rheumatoid, half reached primary completion within 60 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 113. This study's planned 49 months is below that.

Counting every sponsor, half of 390 studies reached it within 50 months; a quarter within 25 and three quarters within 113.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2024
First posted
Dec 2, 2024
StartActual
Nov 7, 2024
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2028
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
7 sites added, 3 sites removed
Show 7 added (7 Germany)
  • Private Practice - Dr. Karin Manger /ID# 287347 · Bamberg, Germany
  • Praxisgemeinschaft Rheumatologie Nephrologie Erlangen /ID# 286648 · Erlangen, Germany
  • Rheumapraxis am Schlachtensee /ID# 287793 · Berlin, Germany
  • Private Practice - Dr Hauke E Heintz /ID# 278081 · Hamburg, Germany
  • Rheumatologische Schwerpunktpraxis Rendsburg /ID# 280069 · Rendsburg, Germany
  • Rheumatologische Schwerpunktpraxis /ID# 280323 · Berlin, Germany
  • Rheumatologisches Versorgungszentrum Steglitz /ID# 289145 · Berlin, Germany
Show 3 removed
  • Private Practice - Dr. Hauke E. Heintz /ID# 278081 · Hamburg, Germany
  • Private Practice - Dr. Jochen Walter /ID# 280069 · Rendsburg, Germany
  • Rheumapraxis Steglitz /ID# 280323 · Berlin, Germany
across 2 updates, Oct 15, 2026 – Nov 19, 2026
Show all 2 updates
  1. Nov 19, 2026
    3 sites added, 2 sites removed
    Show 3 added (3 Germany)
    • Rheumatologische Schwerpunktpraxis Rendsburg /ID# 280069 · Rendsburg, Germany
    • Rheumatologische Schwerpunktpraxis /ID# 280323 · Berlin, Germany
    • Rheumatologisches Versorgungszentrum Steglitz /ID# 289145 · Berlin, Germany
    Show 2 removed
    • Private Practice - Dr. Jochen Walter /ID# 280069 · Rendsburg, Germany
    • Rheumapraxis Steglitz /ID# 280323 · Berlin, Germany
    + 1 other change: verification date
  2. Oct 15, 2026
    4 sites added, 1 site removed
    Show 4 added (4 Germany)
    • Private Practice - Dr. Karin Manger /ID# 287347 · Bamberg, Germany
    • Praxisgemeinschaft Rheumatologie Nephrologie Erlangen /ID# 286648 · Erlangen, Germany
    • Rheumapraxis am Schlachtensee /ID# 287793 · Berlin, Germany
    • Private Practice - Dr Hauke E Heintz /ID# 278081 · Hamburg, Germany
    Show 1 removed
    • Private Practice - Dr. Hauke E. Heintz /ID# 278081 · Hamburg, Germany
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06712628
Lead sponsor
AbbVie
Responsible party
Sponsor
First posted
Dec 2, 2024
Start date
Nov 7, 2024
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 19, 2026

Study contacts

Medical Information Germany
Contact
medinfo.germany@abbvie.com
49 611 1720 1520
ABBVIE INC.
study director · AbbVie

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion